Abstract
This study establishes loss of dependency on EPAC-mTORC1 signaling as hallmark of primary melanoma evolution and targeting this escape mechanism is a promising strategy for metastatic melanoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have